Mondelez Q2 2026: Volume Turns Positive as Recovery Takes Hold

What happened

Mondelez reported Q2 2026 organic revenue growth of 2.2% and, critically, a return to positive volume/mix of +0.7%, marking the first volume growth after quarters of declines. Adjusted EPS of $0.73 fell only 2.7% on a constant-currency basis, a sharp improvement from the ~15% plunge in 2025, signaling that cocoa cost headwinds are abating. Management also announced a 4% dividend increase and returned $1.5 billion to shareholders in the first half, underscoring confidence in the recovery. While free cash flow of $0.7 billion year-to-date remains below the $3+ billion annual pace, the profitability trajectory supports the thesis that gross margins are on the mend. The print directly addresses the prior DeepValue concerns around volume erosion and margin durability, suggesting the earnings trough is past.

Implication

With volume turning positive and adjusted EPS decline narrowing to low single digits, Mondelez is demonstrating the forecasted earnings recovery from cocoa deflation and operational adjustments. The dividend raise and heavy buybacks reflect management’s confidence in continued cash generation and balance sheet strength. While the full-year free cash flow pace needs to accelerate to meet prior targets, the improvement in top-line mix and profitability should support a re-rating if sustained. Given the reduced downside risk now that volume and share trends are improving, the WAIT thesis from the earlier report should shift toward considering accumulation on pullbacks. However, until gross margins fully normalize above 33% and volume/mix stays positive, some caution remains on the pace of recovery.

Thesis delta

The Q2 2026 results provide the first concrete evidence of volume recovery and margin stabilization that the prior WAIT thesis required before turning constructive. The positive volume/mix and sharply improved adjusted EPS trajectory suggest that the worst of the cocoa and elasticity headwinds are behind us, aligning with the bull-case scenario of a $65 implied value. As a result, the thesis migrates from a defensive WAIT to a cautiously bullish outlook, though confirmation of sustained margin gains in subsequent quarters is still needed to fully remove execution risk.